Fig. 4: F13A1, CCR10 and other genes are differentially expressed in allergic and healthy horses in Remission and Clinical Phases. | Genes & Immunity

Fig. 4: F13A1, CCR10 and other genes are differentially expressed in allergic and healthy horses in Remission and Clinical Phases.

From: IgE-binding monocytes upregulate the coagulation cascade in allergic horses

Fig. 4

Normalized read counts of DEGs with greater than +/− 2 FC were compared between healthy (n = 5, gray △□) and allergic (n = 7, orange ▲■) horses. These genes included F13A1, ALX3, SERPINE1, C1R, IGF2BP3 and CCR10. A Read count comparison in January (“Remission Phase”, triangles). CCR10 was not expressed at this timepoint and is excluded. B Read count comparison in August (“Clinical Phase”, squares). Graphs plot individual values and medians. *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001.

Back to article page